AXONICS MODULATION TECHNOLOGIES
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
AXONICS MODULATION TECHNOLOGIES
Industry:
Health Diagnostics Medical Medical Device
Founded:
2012-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.axonics.com
Total Employee:
101+
Status:
Active
Contact:
(949) 396-6322
Total Funding:
735.64 M USD
Technology used in webpage:
SPF Domain Not Resolving Amazon DMARC Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Pound Sterling Japanese Yen
Similar Organizations
Ancora Heart
Ancora Heart is dedicated to helping people with heart failure feel better and live longer.
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Minerva Surgical
Minerva Surgical is a medical device start-up company developing medical devices for women’s healthcare.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Trice Medical
Trice Medical specializes in providing solutions for orthopedic diagnostics.
Current Advisors List
Board_member
2014-03-01
Board_member
2018-12-01
Board_member
2019-04-01
Board_member
2019-03-01
Board_member
2018-04-01
Board_member
2014-01-01
Board_member
2021-01-01
Board_member
2021-07-01
Current Employees Featured
Guangqiang Jiang Co-Founder & Chief Technology Officer @ Axonics Modulation Technologies
Co-Founder & Chief Technology Officer
2013-10-01
Raymond W. Cohen CEO @ Axonics Modulation Technologies
CEO
2013-10-01
Rinda Sama Vice President, Operations and Quality @ Axonics Modulation Technologies
Vice President, Operations and Quality
2014-05-01
Al Ford Chief Commercial Officer @ Axonics Modulation Technologies
Chief Commercial Officer
John Woock Executive Vice President, Chief Marketing & Strategy Officer @ Axonics Modulation Technologies
Executive Vice President, Chief Marketing & Strategy Officer
2021-12-01
Dan L. Dearen President & Chief Financial Officer @ Axonics Modulation Technologies
President & Chief Financial Officer
2013-10-01
Karen Noblett Chief Medical Officer @ Axonics Modulation Technologies
Chief Medical Officer
2017-10-01
Prabodh Mathur Chief Product Development Officer @ Axonics Modulation Technologies
Chief Product Development Officer
2014-05-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-25 | Contura | Contura acquired by Axonics Modulation Technologies | 200 M USD |
Investors List
Gilde Healthcare
Gilde Healthcare investment in Series C - Axonics Modulation Technologies
Longitude Capital
Longitude Capital investment in Series C - Axonics Modulation Technologies
Silicon Valley Bank
Silicon Valley Bank investment in Series C - Axonics Modulation Technologies
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Axonics Modulation Technologies
Gilde Healthcare
Gilde Healthcare investment in Series C - Axonics Modulation Technologies
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Axonics Modulation Technologies
Legend Capital
Legend Capital investment in Series C - Axonics Modulation Technologies
Andera Partners
Andera Partners investment in Series C - Axonics Modulation Technologies
Advent Life Sciences
Advent Life Sciences investment in Series C - Axonics Modulation Technologies
Neomed Management
Neomed Management investment in Series C - Axonics Modulation Technologies
Official Site Inspections
http://www.axonics.com Semrush global rank: 524.17 K Semrush visits lastest month: 64 K
- Host name: 80.182.62.50.host.secureserver.net
- IP address: 50.62.182.80
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Axonics Modulation Technologies"
Axonics® Therapy | Get Your Bladder Back
Jul 8, 2019 Share your contact details to see if you qualify First Name: Last Name: Email: Phone: Zip Code: By clicking “See if I qualify” and submitting this form (the “Quiz”), I agree that Axonics, Inc. (“Axonics”), their agents, …See details»
Our Leadership - Axonics®
Mr. Cohen has served as Chief Executive Officer and member of the board of directors of Axonics since co-founding the company in October 2013. Mr. Cohen is an accredited public company …See details»
Axonics Headquarters & Office Locations | Clay
Dec 13, 2024 Axonics's headquarters is situated at 26 Technology Dr, Irvine, United States. This location serves as the main office for the company, housing its core administrative and …See details»
AXONICS, INC. AMENDED AND RESTATED CHARTER OF THE …
The Board of Directors (the “Board”) of Axonics, Inc., a Delaware corporation (the “Company”) has adopted this Amended and Restated Charter (this “Charter”) of the Nominating and Corporate …See details»
Committee Composition - Axonics, Inc.
The Investor Relations website contains information about Axonics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Axonics, Inc. - AnnualReports.com
Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary and bowel dysfunction. These conditions are caused by a …See details»
Investor Relations - Axonics, Inc.
Nov 7, 2024 Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics …See details»
Boston Scientific Announces Agreement to Acquire Axonics, Inc.
Jan 8, 2024 Axonics expects to deliver net revenue of approximately $366 million in 2023, representing 34% growth over the prior fiscal year. 7 Axonics' revenue growth profile is …See details»
Axonics - Org Chart, Teams, Culture & Jobs - The Org
Axonics® is dedicated to improving the quality of life of people suffering from bladder and bowel dysfunction, conditions that impact the lives of tens of millions of adults globally. The …See details»
Who We Are | Axonics®
Axonics aspires to be the global leader in incontinence therapies by providing customer-centric solutions to treat urinary and bowel dysfunction and improve quality of life for patients and their …See details»
Axonics - Overview, News & Similar companies | ZoomInfo.com
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has …See details»
Axonics Modulation Technologies - Crunchbase
The acquisition by a major player in the medical device industry suggests that Axonics has developed technologies or market presence that are considered valuable assets. Furthermore, …See details»
Axonics Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Axonics has 3 employees at their 1 location and $366.38 m in annual revenue in FY 2023. See insights on Axonics including office locations, competitors, revenue, financials, …See details»
Axonics® Announces Appointment of David M. Demski to Board …
Dec 14, 2020 IRVINE, Calif.--(BUSINESS WIRE)--Dec. 14, 2020-- Axonics Modulation Technologies, Inc. (Nasdaq: AXNX), a medical technology company that has developed and is …See details»
Axonics® Sacral Neuromodulation Therapy
Axonics aspires to be the global leader in incontinence therapies by providing customer-centric solutions to improve the quality of life for patients suffering from urinary and bowel dysfunction. …See details»
Axonics® Advantage
Axonics SNM Therapy for bowel control is indicated for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments. …See details»
Axonics Modulation Technologies - Contacts, Employees, Board …
Organization. Axonics Modulation Technologies . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Number of Board Member and Advisor Profiles 11. …See details»
Axonics vs Medtronic: Which is the Best Sacral Neuromodulation …
1 day ago Whether it’s Axonics vs. Medtronic devices, sacral neuromodulation is typically performed in a series of minor surgical procedures. Axonics vs. Medtronic percutaneous nerve …See details»
Patient Tools, Resources, & Guides - Axonics®
Jul 8, 2019 Axonics Sacral Neuromodulation Therapy is a long-lasting treatment option for overactive bladder, bowel incontinence, and urinary retention. Sacral Neuromodulation is the …See details»
Axonics® Ranked No. 4 on the 2022 Deloitte Technology Fast …
Nov 16, 2022 Axonics reported $180.3 million of revenue in fiscal year 2021 compared to $707,000 in fiscal year 2018, representing a growth rate of 25,401%. This is the second year …See details»